These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 12577096

  • 1. Oligodendroglioma: clinical profile and treatment results.
    Jacob R, Jyothirmayi R, Dalal Y, Nambiar U, Rajan B, Nair MK.
    Neurol India; 2002 Dec; 50(4):462-6. PubMed ID: 12577096
    [Abstract] [Full Text] [Related]

  • 2. Oligodendroglioma: does deferring treatment compromise outcome?
    Feigenberg SJ, Amdur RJ, Morris CG, Mendenhall WM, Marcus RB, Friedman WA.
    Am J Clin Oncol; 2003 Jun; 26(3):e60-6. PubMed ID: 12796617
    [Abstract] [Full Text] [Related]

  • 3. [Long-term results of treatment in patients with oligodendrogliomas and oligoastrocytomas of the cerebral hemispheres].
    Iun'pén V, Oliushin VE, Ulitin AIu, Maslova LN, Petrov AA.
    Zh Vopr Neirokhir Im N N Burdenko; 2008 Jun; (2):6-10; discussion 10-1. PubMed ID: 18720725
    [Abstract] [Full Text] [Related]

  • 4. Treatment of oligodendroglioma: an update.
    Paleologos NA, Cairncross JG.
    Neuro Oncol; 1999 Jan; 1(1):61-8. PubMed ID: 11550303
    [Abstract] [Full Text] [Related]

  • 5. Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II study.
    Jeremic B, Milicic B, Grujicic D, Samardzic M, Antunovic V, Dagovic A, Aleksandrovic J.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):509-14. PubMed ID: 15145170
    [Abstract] [Full Text] [Related]

  • 6. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D, Ruprecht K, Rieckmann P, Roggendorf W, Vince GH, Warmuth-Metz M, Kölbl O, Flentje M.
    BMC Cancer; 2006 Oct 18; 6():247. PubMed ID: 17049083
    [Abstract] [Full Text] [Related]

  • 7. [Results in oligodendroglioma: postoperative radiotherapy combined with chemotherapy].
    Kitahara M, Katakura R, Mashiyama S, Niizuma H, Yoshimoto T, Suzuki J, Mori T, Wada T.
    No Shinkei Geka; 1987 Apr 18; 15(4):397-403. PubMed ID: 3614532
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and feasibility of procarbazine, ranimustine and vincristine chemotherapy, and the role of surgical resection in anaplastic oligodendroglioma.
    Yamamoto M, Iwaasa M, Nonaka M, Tsugu H, Nabeshima K, Fukushima T.
    Anticancer Res; 2005 Apr 18; 25(6A):3715-23. PubMed ID: 16302731
    [Abstract] [Full Text] [Related]

  • 9. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G, Bamberg M, Jürgens H, Kortmann RD, Sörensen N, Wiestler OD, Göbel U.
    Klin Padiatr; 2004 Apr 18; 216(3):141-9. PubMed ID: 15175958
    [Abstract] [Full Text] [Related]

  • 10. [Results of multimodal treatment of patients with glial tumors of cerebral hemispheres].
    Cheremisin VM, Gaĭdar BV, Asaturian MA, Korobkova IM, Trufanov GE, Anosov NA.
    Vestn Rentgenol Radiol; 1995 Apr 18; (4):13-5. PubMed ID: 8571528
    [Abstract] [Full Text] [Related]

  • 11. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
    Law M, Oh S, Johnson G, Babb JS, Zagzag D, Golfinos J, Kelly PJ.
    Neurosurgery; 2006 Jun 18; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
    [Abstract] [Full Text] [Related]

  • 12. Treatment of oligodendrogliomas with or without postoperative irradiation.
    Wallner KE, Gonzales M, Sheline GE.
    J Neurosurg; 1988 May 18; 68(5):684-8. PubMed ID: 3357029
    [Abstract] [Full Text] [Related]

  • 13. Combined surgery, radiation, and chemotherapy for oligodendroglial gliomatosis cerebri.
    Fukushima Y, Nakagawa H, Tamura M.
    Br J Neurosurg; 2004 Jun 18; 18(3):306-10. PubMed ID: 15327240
    [Abstract] [Full Text] [Related]

  • 14. Clear cell ependymoma: a clinicopathologic and radiographic analysis of 10 patients.
    Fouladi M, Helton K, Dalton J, Gilger E, Gajjar A, Merchant T, Kun L, Newsham I, Burger P, Fuller C.
    Cancer; 2003 Nov 15; 98(10):2232-44. PubMed ID: 14601094
    [Abstract] [Full Text] [Related]

  • 15. Factors possibly influencing the prognosis of oligodendroglioma.
    Sun ZM, Genka S, Shitara N, Akanuma A, Takakura K.
    Neurosurgery; 1988 May 15; 22(5):886-91. PubMed ID: 3380278
    [Abstract] [Full Text] [Related]

  • 16. Should radiotherapy for low-grade glioma be given immediately after surgery or at the time of progression?
    Rosenfeld MR.
    Nat Clin Pract Neurol; 2006 Mar 15; 2(3):128-9. PubMed ID: 16932536
    [No Abstract] [Full Text] [Related]

  • 17. Postoperative radiotherapy and chemotherapy in the management of oligodendroglioma: single institutional review of 88 patients.
    Ozyigit G, Onal C, Gurkaynak M, Soylemezoglu F, Zorlu F.
    J Neurooncol; 2005 Nov 15; 75(2):189-93. PubMed ID: 16132506
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.